Gut health is closely tied to overall immunity. As antibiotic resistance rises, IgY antibodies—naturally derived from egg yolk—are emerging as a powerful and targeted solution to protect the intestinal system without disrupting the microbiota.
What the Research Says
- A meta-analysis by Diraviyam et al. (2014) found that oral IgY significantly reduced the risk of diarrhea in animals such as piglets, rodents, calves, and chickens.
Read the study on PLOS ONE - Further research confirms that IgY antibodies specific to ETEC (Enterotoxigenic Escherichia coli) reduce bacterial adhesion, toxin production, and intestinal inflammation in mice and piglets.
Study available on PubMed Central
Why It Matters
- IgY acts directly in the gut lumen, targeting pathogens without harming beneficial flora.
- Unlike antibiotics, it does not contribute to microbial resistance and is safe for long-term use.
Backed by robust data, IgY-based formulations are a promising tool in preventing and managing gastrointestinal infections — naturally, effectively, and safely.







